Koyfin Home > Directory > Health Care > Amgen Inc > Net Debt / EBITDA

Amgen Inc Net Debt / EBITDA Chart (AMGN)

Amgen Inc annual/quarterly Net Debt / EBITDA from 2010 to 2020. Net Debt / EBITDA is a measure of leverage for a company by dividing the Debt less Cash on hand vs. EBITDA.
  • Amgen Inc Net Debt / EBITDA for the quarter ending September 09, 2020 was $2m a -23.34% decrease of 0m year over year
  • Amgen Inc Net Debt / EBITDA for the last 12 months ending September 09, 2020 was $2m a -4.07% decrease of 0m year over year
  • Amgen Inc Annual Net Debt / EBITDA for 2019 was $2m a 79.46% increase of 1m from 2018
  • Amgen Inc Annual Net Debt / EBITDA for 2018 was $0m a 239.65% increase of 1m from 2017
  • Amgen Inc Annual Net Debt / EBITDA for 2017 was $-1m a 43.52% decrease of 0m from 2016
Other Ratios Metrics:
  • Amgen Inc Total Debt / Capital for the quarter ending December 12, 2018 was $73m a 4.94% increase of 4m year over year
  • Amgen Inc Other Liabilities for the quarter ending December 12, 2018 was $10,918m a -7.23% decrease of -789m year over year
  • Amgen Inc Total Debt / Equity for the quarter ending December 12, 2018 was $271m a 16.17% increase of 44m year over year
View Chart On Koyfin

Quarterly AMGN Net Debt / EBITDA Data

09/2020$2m
06/2020$2m
03/2020$2m
12/2019$2m
09/2019$1m
06/2019$1m
03/2019$1m
12/2018$0m
09/2018$0m
06/2018$0m

Annual AMGN Net Debt / EBITDA Data

2019$2m
2018$0m
2017$-1m
2016$0m
2015$0m
2014$0m
2013$2m
2012$0m
2011$0m
2010$-1m